Mack Savage, M.D.
NPI 1396159208 · Ophthalmology Physician · Sedalia, MO
Enrolled with Medicare as Practitioner - Ophthalmology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1396159208
- Entity type
- Individual
- Primary specialty
- Ophthalmology PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.
- Sex
- Male
- Sole proprietor
- No
- License
- 4301114302 (MI)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
11 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
4,906 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Imaging of Retina92134 | 2,050 | $37 |
| Injection of Drug Into Eye67028 | 1,557 | $128 |
| Established Patient Problem Focused Exam of Visual System92012 | 299 | $87 |
| Photography of the Retina92250 | 257 | $36 |
| Established Patient Complete Exam of Visual System92014 | 224 | $123 |
| New Patient Complete Exam of Visual System92004 | 160 | $146 |
| Unclassified BiologicsJ3590 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 8 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Prednisolone Acetate | 171 | 99 |
| Ofloxacin | 106 | 83 |
| Brimonidine Tartrate | 50 | 28 |
| Timolol Maleate | 42 | 21 |
| Ketorolac Tromethamine | 31 | 17 |
| Dorzolamide Hcl | 18 | 14 |
| Dorzolamide Hcl/Timolol Maleatbrand: Dorzolamide-Timolol | 17 | — |
| Brimonidine Tartrate/Timolol |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$785 across 21 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2014-06-18
- Last updated
- 2025-05-28
- Certified
- 2025-05-28
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.